Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
Stanford University
Stanford University
UNC Lineberger Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Fudan University
Allogene Therapeutics
Medical College of Wisconsin
Novartis
Second Xiangya Hospital of Central South University
H. Lee Moffitt Cancer Center and Research Institute
MedSIR
Memorial Sloan Kettering Cancer Center
University of Chicago
University of Alabama at Birmingham
Ruijin Hospital
Shanghai Zhongshan Hospital
French Innovative Leukemia Organisation
University of Rochester
M.D. Anderson Cancer Center
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Yale University
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
University of Maryland, Baltimore
Tata Memorial Centre
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
Peter MacCallum Cancer Centre, Australia
Masonic Cancer Center, University of Minnesota
Ruijin Hospital
Hospital Universitario Dr. Jose E. Gonzalez
Gruppo Italiano Malattie EMatologiche dell'Adulto
Polish Lymphoma Research Group
Technische Universität Dresden
University of Southampton
Institute of Hematology & Blood Diseases Hospital, China
University of British Columbia
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing 302 Hospital
Washington University School of Medicine
Gruppo Oncologico del Nord-Ovest
Fundació Sant Joan de Déu
Ludwig-Maximilians - University of Munich
St. Anna Kinderkrebsforschung
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
University of Leipzig